List of Tables
Table 1. Global Menstrual Regulating Drug Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Menstrual Regulating Drug Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Menstrual Regulating Drug Market Competitive Situation by Manufacturers in 2025
Table 4. Global Menstrual Regulating Drug Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Menstrual Regulating Drug Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Menstrual Regulating Drug Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Menstrual Regulating Drug Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Menstrual Regulating Drug Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Menstrual Regulating Drug, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Menstrual Regulating Drug, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Menstrual Regulating Drug, Product Types and Applications
Table 12. Global Key Manufacturers of Menstrual Regulating Drug, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Menstrual Regulating Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Menstrual Regulating Drug Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Menstrual Regulating Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Menstrual Regulating Drug Sales by Region (K Units), 2021–2026
Table 18. Global Menstrual Regulating Drug Sales Market Share by Region (2021–2026)
Table 19. Global Menstrual Regulating Drug Sales by Region (K Units), 2027–2032
Table 20. Global Menstrual Regulating Drug Sales Market Share by Region (2027–2032)
Table 21. Global Menstrual Regulating Drug Revenue by Region (US$ Million), 2021–2026
Table 22. Global Menstrual Regulating Drug Revenue Market Share by Region (2021–2026)
Table 23. Global Menstrual Regulating Drug Revenue by Region (US$ Million), 2027–2032
Table 24. Global Menstrual Regulating Drug Revenue Market Share by Region (2027–2032)
Table 25. North America Menstrual Regulating Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Menstrual Regulating Drug Sales by Country (K Units), 2021–2026
Table 27. North America Menstrual Regulating Drug Sales by Country (K Units), 2027–2032
Table 28. North America Menstrual Regulating Drug Revenue by Country (US$ Million), 2021–2026
Table 29. North America Menstrual Regulating Drug Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Menstrual Regulating Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Menstrual Regulating Drug Sales by Country (K Units), 2021–2026
Table 32. Europe Menstrual Regulating Drug Sales by Country (K Units), 2027–2032
Table 33. Europe Menstrual Regulating Drug Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Menstrual Regulating Drug Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Menstrual Regulating Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Menstrual Regulating Drug Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Menstrual Regulating Drug Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Menstrual Regulating Drug Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Menstrual Regulating Drug Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Menstrual Regulating Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Menstrual Regulating Drug Sales by Country (K Units), 2021–2026
Table 42. Latin America Menstrual Regulating Drug Sales by Country (K Units), 2027–2032
Table 43. Latin America Menstrual Regulating Drug Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Menstrual Regulating Drug Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Menstrual Regulating Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Menstrual Regulating Drug Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Menstrual Regulating Drug Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Menstrual Regulating Drug Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Menstrual Regulating Drug Revenue by Country (US$ Million), 2027–2032
Table 50. Global Menstrual Regulating Drug Sales (K Units) by Type (2021–2026)
Table 51. Global Menstrual Regulating Drug Sales (K Units) by Type (2027–2032)
Table 52. Global Menstrual Regulating Drug Sales Market Share by Type (2021–2026)
Table 53. Global Menstrual Regulating Drug Sales Market Share by Type (2027–2032)
Table 54. Global Menstrual Regulating Drug Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Menstrual Regulating Drug Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Menstrual Regulating Drug Revenue Market Share by Type (2021–2026)
Table 57. Global Menstrual Regulating Drug Revenue Market Share by Type (2027–2032)
Table 58. Global Menstrual Regulating Drug Price (US$/Unit) by Type (2021–2026)
Table 59. Global Menstrual Regulating Drug Price (US$/Unit) by Type (2027–2032)
Table 60. Global Menstrual Regulating Drug Sales (K Units) by Application (2021–2026)
Table 61. Global Menstrual Regulating Drug Sales (K Units) by Application (2027–2032)
Table 62. Global Menstrual Regulating Drug Sales Market Share by Application (2021–2026)
Table 63. Global Menstrual Regulating Drug Sales Market Share by Application (2027–2032)
Table 64. Global Menstrual Regulating Drug Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Menstrual Regulating Drug Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Menstrual Regulating Drug Revenue Market Share by Application (2021–2026)
Table 67. Global Menstrual Regulating Drug Revenue Market Share by Application (2027–2032)
Table 68. Global Menstrual Regulating Drug Price (US$/Unit) by Application (2021–2026)
Table 69. Global Menstrual Regulating Drug Price (US$/Unit) by Application (2027–2032)
Table 70. Bayer AG Company Information
Table 71. Bayer AG Description and Business Overview
Table 72. Bayer AG Menstrual Regulating Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Bayer AG Menstrual Regulating Drug Product
Table 74. Bayer AG Recent Developments/Updates
Table 75. Pfizer Inc. Company Information
Table 76. Pfizer Inc. Description and Business Overview
Table 77. Pfizer Inc. Menstrual Regulating Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer Inc. Menstrual Regulating Drug Product
Table 79. Pfizer Inc. Recent Developments/Updates
Table 80. Teva Pharmaceutical Industries Ltd. Company Information
Table 81. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 82. Teva Pharmaceutical Industries Ltd. Menstrual Regulating Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Teva Pharmaceutical Industries Ltd. Menstrual Regulating Drug Product
Table 84. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 85. Novartis AG Company Information
Table 86. Novartis AG Description and Business Overview
Table 87. Novartis AG Menstrual Regulating Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Novartis AG Menstrual Regulating Drug Product
Table 89. Novartis AG Recent Developments/Updates
Table 90. Johnson & Johnson Company Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Menstrual Regulating Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Johnson & Johnson Menstrual Regulating Drug Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. Merck & Co., Inc. Company Information
Table 96. Merck & Co., Inc. Description and Business Overview
Table 97. Merck & Co., Inc. Menstrual Regulating Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Merck & Co., Inc. Menstrual Regulating Drug Product
Table 99. Merck & Co., Inc. Recent Developments/Updates
Table 100. AbbVie Inc. Company Information
Table 101. AbbVie Inc. Description and Business Overview
Table 102. AbbVie Inc. Menstrual Regulating Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. AbbVie Inc. Menstrual Regulating Drug Product
Table 104. AbbVie Inc. Recent Developments/Updates
Table 105. Allergan plc Company Information
Table 106. Allergan plc Description and Business Overview
Table 107. Allergan plc Menstrual Regulating Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Allergan plc Menstrual Regulating Drug Product
Table 109. Allergan plc Recent Developments/Updates
Table 110. Mylan N.V. Company Information
Table 111. Mylan N.V. Description and Business Overview
Table 112. Mylan N.V. Menstrual Regulating Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Mylan N.V. Menstrual Regulating Drug Product
Table 114. Mylan N.V. Recent Developments/Updates
Table 115. GlaxoSmithKline plc Company Information
Table 116. GlaxoSmithKline plc Description and Business Overview
Table 117. GlaxoSmithKline plc Menstrual Regulating Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. GlaxoSmithKline plc Menstrual Regulating Drug Product
Table 119. GlaxoSmithKline plc Recent Developments/Updates
Table 120. Lupin Limited Company Information
Table 121. Lupin Limited Description and Business Overview
Table 122. Lupin Limited Menstrual Regulating Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Lupin Limited Menstrual Regulating Drug Product
Table 124. Lupin Limited Recent Developments/Updates
Table 125. Sun Pharmaceutical Industries Ltd. Company Information
Table 126. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 127. Sun Pharmaceutical Industries Ltd. Menstrual Regulating Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Sun Pharmaceutical Industries Ltd. Menstrual Regulating Drug Product
Table 129. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 130. HRA Pharma Company Information
Table 131. HRA Pharma Description and Business Overview
Table 132. HRA Pharma Menstrual Regulating Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. HRA Pharma Menstrual Regulating Drug Product
Table 134. HRA Pharma Recent Developments/Updates
Table 135. Sandoz International GmbH Company Information
Table 136. Sandoz International GmbH Description and Business Overview
Table 137. Sandoz International GmbH Menstrual Regulating Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Sandoz International GmbH Menstrual Regulating Drug Product
Table 139. Sandoz International GmbH Recent Developments/Updates
Table 140. Dr. Reddy's Laboratories Ltd. Company Information
Table 141. Dr. Reddy's Laboratories Ltd. Description and Business Overview
Table 142. Dr. Reddy's Laboratories Ltd. Menstrual Regulating Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Dr. Reddy's Laboratories Ltd. Menstrual Regulating Drug Product
Table 144. Dr. Reddy's Laboratories Ltd. Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Menstrual Regulating Drug Distributors List
Table 148. Menstrual Regulating Drug Customers List
Table 149. Menstrual Regulating Drug Market Trends
Table 150. Menstrual Regulating Drug Market Drivers
Table 151. Menstrual Regulating Drug Market Challenges
Table 152. Menstrual Regulating Drug Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Menstrual Regulating Drug
Figure 2. Global Menstrual Regulating Drug Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Menstrual Regulating Drug Market Share by Type: 2025 & 2032
Figure 4. Contraceptive Pills Product Picture
Figure 5. Non-contraceptive Pills Product Picture
Figure 6. Global Menstrual Regulating Drug Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Menstrual Regulating Drug Market Share by Application: 2025 & 2032
Figure 8. Irregular Menstruation
Figure 9. Menstrual Pain
Figure 10. Others
Figure 11. Global Menstrual Regulating Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Menstrual Regulating Drug Market Size (US$ Million), 2021–2032
Figure 13. Global Menstrual Regulating Drug Sales (K Units), 2021–2032
Figure 14. Global Menstrual Regulating Drug Average Price (US$/Unit), 2021–2032
Figure 15. Menstrual Regulating Drug Report Years Considered
Figure 16. Menstrual Regulating Drug Sales Share by Manufacturers in 2025
Figure 17. Global Menstrual Regulating Drug Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Menstrual Regulating Drug Players: Market Share by Revenue in Menstrual Regulating Drug in 2025
Figure 19. Menstrual Regulating Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Menstrual Regulating Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Menstrual Regulating Drug Sales Market Share by Country (2021–2032)
Figure 22. North America Menstrual Regulating Drug Revenue Market Share by Country (2021–2032)
Figure 23. United States Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Menstrual Regulating Drug Sales Market Share by Country (2021–2032)
Figure 26. Europe Menstrual Regulating Drug Revenue Market Share by Country (2021–2032)
Figure 27. Germany Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Menstrual Regulating Drug Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Menstrual Regulating Drug Revenue Market Share by Region (2021–2032)
Figure 34. China Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Menstrual Regulating Drug Sales Market Share by Country (2021–2032)
Figure 42. Latin America Menstrual Regulating Drug Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Menstrual Regulating Drug Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Menstrual Regulating Drug Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Menstrual Regulating Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Menstrual Regulating Drug by Type (2021–2032)
Figure 53. Global Revenue Market Share of Menstrual Regulating Drug by Type (2021–2032)
Figure 54. Global Menstrual Regulating Drug Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Menstrual Regulating Drug by Application (2021–2032)
Figure 56. Global Revenue Market Share of Menstrual Regulating Drug by Application (2021–2032)
Figure 57. Global Menstrual Regulating Drug Price (US$/Unit) by Application (2021–2032)
Figure 58. Menstrual Regulating Drug Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
